| 1 | choose language polski english | | | | | | | 1 | 0.56% |
| 2 | and implementation of new | | | | | | | 1 | 0.56% |
| 3 | radiotherapy department the medical | | | | | | | 1 | 0.56% |
| 4 | field is also the | | | | | | | 1 | 0.56% |
| 5 | is also the monitoring | | | | | | | 1 | 0.56% |
| 6 | also the monitoring and | | | | | | | 1 | 0.56% |
| 7 | the monitoring and implementation | | | | | | | 1 | 0.56% |
| 8 | monitoring and implementation of | | | | | | | 1 | 0.56% |
| 9 | implementation of new procedures | | | | | | | 1 | 0.56% |
| 10 | provide catchment radiotherapy department | | | | | | | 1 | 0.56% |
| 11 | andtrends therefore our team | | | | | | | 1 | 0.56% |
| 12 | therefore our team participates | | | | | | | 1 | 0.56% |
| 13 | our team participates in | | | | | | | 1 | 0.56% |
| 14 | team participates in clinical | | | | | | | 1 | 0.56% |
| 15 | participates in clinical trials | | | | | | | 1 | 0.56% |
| 16 | in clinical trials of | | | | | | | 1 | 0.56% |
| 17 | catchment radiotherapy department the | | | | | | | 1 | 0.56% |
| 18 | radiotherapy provide catchment radiotherapy | | | | | | | 1 | 0.56% |
| 19 | and international participating in | | | | | | | 1 | 0.56% |
| 20 | monitoring of patients after | | | | | | | 1 | 0.56% |
| 21 | tactics of treatment of | | | | | | | 1 | 0.56% |
| 22 | of treatment of malignant | | | | | | | 1 | 0.56% |
| 23 | treatment of malignant tumors | | | | | | | 1 | 0.56% |
| 24 | of malignant tumors preventive | | | | | | | 1 | 0.56% |
| 25 | care longterm monitoring of | | | | | | | 1 | 0.56% |
| 26 | longterm monitoring of patients | | | | | | | 1 | 0.56% |
| 27 | of patients after completed | | | | | | | 1 | 0.56% |
| 28 | biological and supportive therapy | | | | | | | 1 | 0.56% |
| 29 | patients after completed cancer | | | | | | | 1 | 0.56% |
| 30 | after completed cancer treatment | | | | | | | 1 | 0.56% |
| 31 | language polski english uk | | | | | | | 1 | 0.56% |
| 32 | we provide cytostatic hormonal | | | | | | | 1 | 0.56% |
| 33 | provide cytostatic hormonal biological | | | | | | | 1 | 0.56% |
| 34 | cytostatic hormonal biological and | | | | | | | 1 | 0.56% |
| 35 | hormonal biological and supportive | | | | | | | 1 | 0.56% |
| 36 | domestic and international participating | | | | | | | 1 | 0.56% |
| 37 | international participating in conferences | | | | | | | 1 | 0.56% |
| 38 | determination of tactics of | | | | | | | 1 | 0.56% |
| 39 | drugs a team of | | | | | | | 1 | 0.56% |
| 40 | was included in an | | | | | | | 1 | 0.56% |